This Government Contract opportunity from Department Of Defense was posted on August 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Manufacturing of Gabapentin 100 mg Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the pharmaceutical manufacturing of FDA-compliant gabapentin 100 mg capsules. The scope of work includes formulation, encapsulation, quality control, and the provision of batch documentation adhering to DLA standards, with the final product delivered in 100-count bottles. The opportunity was posted on August 12, 2026, with a response deadline of August 18, 2026. Classified under NAICS code 325412, the place of performance is located in FPO 96672.
General Info
Agency
NAICS
Place of Performance
FPO, AP, 96672, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4627.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
GABAPENTIN CAPSULES
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS